Reliq Health (OTC: RQHTF) SaaS HealthTech now at $24 MIL run rate - accelerating to $100 MIL + '23

preview_player
Показать описание
NEXT SUPER STOCK Reliq Health Tech (OTC: RQHTF) is now at a $24 million run rate - accelerating to $100 million+ SaaS HealthTech revenues in 2023. This positions RQHTF on path to a potential +10X upside -($10.00+) stock in the next 12 months. Watch this latest interview and decide for yourself.
NEXT SUPER STOCK Reliq Health (OTC: RQHTF) (TSX: RHT) January 5 2022 livestream
Рекомендации по теме
Комментарии
Автор

i m very excited for 2022. i m calling min $10 per share by the end of the year.

nedzadmahmutovic
Автор

I love this company. If I could I would mortgage my house for more shares.

toastturtle
Автор

During n next interview can u ask for some forward guidance? expected profitability? Net income and EBITDA? Are they going to stop issuing option? There are lots of shares dilution going on.

TonyYIsOn
Автор

Lisa, has shown resiliency and should be congratulated for her latest deliverables

nickthomas
Автор

And to add...WSR you say 24 mil revenue run rate. How do you know that? Based on financials and what Lisa has said in the past how is it even possible to have a modicum of confidence in that? You simply can't. You are simply a paid promoter to a CEO who has delusions on how to communicate to a stock market.

ronp